Valuation: AngioDynamics, Inc.

Market Cap 556M 488M 454M 416M 782M 53.5B 794M 5.39B 2.11B 26.3B 2.09B 2.04B 90.93B P/E 2027 *
-25.5x
P/E 2028 * -45.8x
Enterprise Value 556M 488M 454M 416M 782M 53.5B 794M 5.39B 2.11B 26.3B 2.09B 2.04B 90.93B EV / Sales 2027 *
1.65x
EV / Sales 2028 * 1.56x
Free-Float
86.62%
Yield 2027 *
-
Yield 2028 * -
1 day+1.00%
1 week+0.96%
Current month+4.84%
1 month+5.33%
3 months+22.88%
6 months+32.04%
Current year+6.23%
1 week 13.22
Extreme 13.22
14.36
1 month 12.31
Extreme 12.31
15.2
Current year 9.39
Extreme 9.39
15.2
1 year 8.36
Extreme 8.36
15.2
3 years 5.26
Extreme 5.26
15.2
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2016
Director of Finance/CFO 51 23/10/2019
Chief Tech/Sci/R&D Officer - 01/01/2017
Director TitleAgeSince
Chairman 65 29/04/2014
Director/Board Member 67 29/01/2007
Director/Board Member 62 01/04/2016
Date Insider Type Main position Quantity % Market Cap.
20/07/26 Tax

Chief Executive Officer

-4,223 0.0102%
20/07/26 Tax

Chief Financial Officer

-717 0.0017%
20/07/26 Tax

General Counsel

-251 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+1.00%+0.96%+49.73%+55.53% 556M
+2.40%+2.49%-17.87%-9.97% 175B
+1.51%-0.05%-9.92%-6.31% 105B
+1.18%+0.09%+6.10%+60.97% 59.35B
-1.13%-1.96%+32.11%+56.38% 50.71B
+2.16%-1.25%-14.94%-44.21% 42.15B
+3.07%-2.17% - - 31.82B
+1.79%-6.71%-17.56%-44.01% 27.2B
-5.10%-6.07%+20.56%-10.52% 25.11B
+1.79%-1.77%-5.83%-7.83% 20.53B
Average +0.86%-3.58%+4.71%+5.56% 53.79B
Weighted average by Cap. +1.38%-1.52%-5.67%+1.21%

Financials

2027 *2028 *
Net sales 337M 296M 276M 253M 475M 32.48B 482M 3.27B 1.28B 15.97B 1.27B 1.24B 55.22B 355M 312M 290M 266M 500M 34.2B 508M 3.44B 1.35B 16.82B 1.33B 1.3B 58.14B
Net income -22.3M -19.59M -18.21M -16.71M -31.4M -2.15B -31.89M -216M -84.5M -1.06B -83.71M -81.91M -3.65B -12.67M -11.13M -10.35M -9.49M -17.84M -1.22B -18.11M -123M -48M -600M -47.55M -46.53M -2.07B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
24/07/26 $13.62 +1.34% 143,709
23/07/26 $13.44 -2.75% 288,811
22/07/26 $13.82 -2.81% 405,429
21/07/26 $14.22 +3.72% 602,535
20/07/26 $13.71 +1.48% 500,576
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.44USD
Average target price
20.00USD
Spread / Average Target
+48.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock